Saundra Pelletier’s Post

This acquisition by Evofem represents an important step in expanding the offerings in the product pipeline.

#Testosterone_Replacement_Therapy Market Positioned for Noteworthy Growth During the Assessment Period 2023-2032 https://lnkd.in/d39hTWiK The rising prevalence of erectile dysfunction, and growing incidence rate of low sex drive, and lowered sperm count or volume drive the #testosterone #replacement #therapy #market. Erectile dysfunction is a significant and becoming a #common #medical #problem. It is becoming more prevalent in the age below 40. Currently, it affects 5%-10% of men below the age of 40. AbbVie Bayer Actavis plc (now Allergan) Eli Lilly and Company Endo Pharmaceuticals Mylan Kyowa Kirin International plc. Novartis Pfizer #Testosterone_Replacement_Therapy #healthcare #business_opportunities #marketanalysis #marketresearch #opportunities #business #future 

#Testosterone_Replacement_Therapy Market - Upcoming Business Future Growth and Forecast To 2030. >> https://lnkd.in/d39hTWiK The rising prevalence of erectile dysfunction, and growing incidence rate of low sex drive, and lowered sperm count or volume drive the #testosterone #replacement #therapy #market. Erectile dysfunction is a significant and becoming a #common #medical #problem. It is becoming more prevalent in the age below 40. Currently, it affects 5%-10% of men below the age of 40. AbbVie Bayer Actavis plc (now Allergan) Eli Lilly and Company Endo Pharmaceuticals Mylan Kyowa Kirin International plc. Novartis Pfizer #Testosterone_Replacement_Therapy #healthcare #business_opportunities #marketanalysis #marketresearch #opportunities #business #future 

#Testosterone_Replacement_Therapy Market Growth Set to Surge Significantly during 2023-2032  >> https://lnkd.in/gCADqmpN #Testosterone replacement #therapy or androgen replacement therapy is a therapeutic practice used to treat men with low testosterone levels. Low testosterone occurs with age or as a result of a #medical condition which causes low sex drive, fewer spontaneous erections, erectile dysfunction, lowered sperm count or volume, trouble sleeping, unusual loss of #muscle and #bone #density, and unexplained weight #gain. AbbVie, Bayer, Allergan, Eli Lilly and Company, Endo International plc BSP Pharmaceuticals S.p.A., Mylan, Kyowa Kirin International plc., Novartis, Pfizer #therapy #therapyjourney #therapydog #gaindetemps #gainesvillefl #gainesville #gainingtogether #medicalassistant #medicalbillingandcoding #medicalbillingcompany

Exciting news in the pharmaceutical world! Gonadorelin, a synthetic hormone, is making waves in both diagnostics and treatments. It's used to: Diagnose: - Gonadorelin tests pituitary gland function by stimulating the gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Doctors measure the levels of these hormones in the blood after administering Gonadorelin to assess the gland's response and overall function. Treat: -Gonadorelin treats conditions like delayed puberty and infertility by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. These hormones are essential for sexual development and reproductive function. By boosting their levels, Gonadorelin helps regulate and restore normal reproductive processes. #Pharmaceuticals #Gonadorelin #Healthcare

Sex-specific indications for psilocybin micro-dosing elucidated by an innovative research collaboration between Drug Science and Red Light Holland Corp micro-dosing app: Drug Science has leveraged real world data provided by Red Light Holland Corp's state of the art micro-dosing app from 929 psilocybin users in the Netherlands to provide key insights into usage patterns and gender-specific applications of psilocybin micro-dosing. Key findings of interest: - Indications for therapeutic applications for conditions such as PMS, menopause, and migraines, conditions which specifically or disproportionately effect women. - Dosing schedules differ between genders, with certain age brackets of females showing higher adherence. - Female participation in this study is at a higher proportion than average micro-dosing studies, which typically report less than 30% female involvement, indicating women's growing interest in micro-dosing. Read more here:  https://lnkd.in/gqNXrVeR This data is invaluable for regulating bodies in the growth of the psychedelic industry to maintain a focus on sex-based variance and application. Well done!

Thoughts on this? >> Researchers seek FDA transparency on use of surrogate endpoints outside of oncology >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #healthcare #productmarketing

Mechanisms of Contraceptive-Induced Disorders: An Analytical Overview Galyna Cordero, QPPV, Head of pharmacovigilance department, clinical expert JSC"Farmak" Abstract Hormonal contraceptives, encompassing combined oral contraceptives (COCs) and progestin-only formulations, are instrumental in modern reproductive healthcare. Despite their efficacy, their use is linked to various adverse effects that pose significant clinical challenges. Understanding the mechanisms behind these contraceptive-induced disorders is crucial for developing strategies to mitigate risks and enhance patient safety. The mechanisms of contraceptive-induced disorders are complex and multifactorial, involving hormonal imbalances, molecular interactions, and system-specific effects. A thorough understanding of these mechanisms is essential for healthcare providers to identify at-risk individuals, implement appropriate monitoring and management strategies, and optimize the safety and efficacy of hormonal contraceptive use. Future research should continue to explore these mechanisms to develop safer contraceptive options and improve patient outcomes. If You would like to get new actual drug safety/pharmacovigilance knowledge follow me, and subscribe to my YouTube channel: Drug safety from Galyna Cordero: https://lnkd.in/dFbjtrf3 #contraceptive #thromboembolic #hypertension #hepatoxicity #cancer #progestin #estrogen #pharmacoviigilance #drugsafety #drug_safety #patientsafety #medicine #pharmacology #treatment

New Report: "Organ Donation After Overdose Death" 📄 As younger Americans develop chronic disease with the potential for organ failure and our aging population increases, the waitlist for hopeful transplant recipients has increased. There has also been a surge of drug overdose deaths of people who were previously healthy and would otherwise be ideal organ donor candidates. Successful transplant outcomes have been reported for donors with a range of toxicities, however, controversy exists around the viability of organs after illicit drug overdose. This report, from the American College of Medical Toxicology and developed in partnership with ORN, examines cases in which organ donation occurred to highlight the considerations of organ viability after a substance use-related overdose. Read and download the full report here: https://bit.ly/3LIt0Ki #OpioidResponseNetwork #AmericanCollegeofMedicalToxicology #Overdose #SubstanceUseDisorder

𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐆𝐨𝐧𝐚𝐝𝐨𝐭𝐫𝐨𝐩𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬, 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gVeWpzEi The term "Chronic Gonadotropin Market" doesn't align with any recognized medical or pharmaceutical term. However, if you're referring to human chorionic gonadotropin (hCG), it's a hormone produced during pregnancy that is often used in the medical field for various purposes, including fertility treatments and as a tumor marker. The market for human chorionic gonadotropin (hCG) and related products encompasses a range of pharmaceuticals, diagnostic tests, and fertility treatments. This market has seen significant growth due to factors such as increasing infertility rates, advancements in assisted reproductive technologies, and the rising prevalence of hormonal disorders. #Company Ferring Pharmaceuticals Fresenius Kabi Merck Group Actiza Pharmaceutical Cigna Healthcare Sun Pharmaceutical Lupin Cipla Zydus Group KAMIYA BIOMEDICAL COMPANY, LLC #Type Human Chronic Gonadotropin Animal Chronic Gonadotropin #Application Hospital Research Institutions Others #ChronicGonadotropin,#HormoneTherapy,#ReproductiveHealth,#FertilityTreatment,#MedicalResearch,#Pharmaceuticals,#Healthcare,#Endocrinology,#HormonalDisorders,#ReproductiveMedicine